Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Concentration-guided, Exploratory Study of Mavacameten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction

NCT03442764 is registered in ClinicalTrials.gov with MyoKardia, Inc. as lead sponsor.

NCT NCT03442764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03442764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Concentration-guided, Exploratory Study of Mavacameten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction
Lead sponsor
MyoKardia, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 30, 2018
Completion date
January 7, 2020
Enrollment
59 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

non-obstructive hypertrophic cardiomyopathy